A Study of OV101 in Individuals With Angelman Syndrome (AS)
Public ClinicalTrials.gov record NCT04106557. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study to Evaluate the Efficacy and Safety of OV101 in Pediatric Individuals With Angelman Syndrome
Study identification
- NCT ID
- NCT04106557
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Healx AI
- Industry
- Enrollment
- 104 participants
Conditions and interventions
Interventions
- Gaboxadol Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 8, 2019
- Primary completion
- Nov 1, 2020
- Completion
- Nov 1, 2020
- Last update posted
- Jan 7, 2024
2019 – 2020
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ovid Therapeutics Investigative Site | Phoenix | Arizona | 85006 | — |
| Ovid Therapeutics Investigative Site | San Diego | California | 92024 | — |
| Ovid Therapeutics Investigative Site | Chicago | Illinois | 60612 | — |
| Ovid Therapeutics Investigative Site | Boston | Massachusetts | 02115 | — |
| Ovid Therapeutics Investigative Site | Lexington | Massachusetts | 02421 | — |
| Ovid Therapeutics Investigative Site | Cincinnati | Ohio | 45229 | — |
| Ovid Therapeutics Investigative Site | Media | Pennsylvania | 19063 | — |
| Ovid Therapeutics Investigative Site | Nashville | Tennessee | 37232 | — |
| Ovid Therapeutics Investigative Site | Tacoma | Washington | 85006 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04106557, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 7, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04106557 live on ClinicalTrials.gov.